Dataset Preview
Duplicate
The full dataset viewer is not available (click to read why). Only showing a preview of the rows.
The dataset generation failed
Error code:   DatasetGenerationError
Exception:    CastError
Message:      Couldn't cast
input: string
output: string
rejected: string
chosen: string
prompt: string
to
{'prompt': Value('string'), 'chosen': Value('string'), 'rejected': Value('string')}
because column names don't match
Traceback:    Traceback (most recent call last):
                File "/usr/local/lib/python3.14/site-packages/datasets/builder.py", line 1827, in _prepare_split_single
                  for key, table in generator:
                                    ^^^^^^^^^
                File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 613, in wrapped
                  for item in generator(*args, **kwargs):
                              ~~~~~~~~~^^^^^^^^^^^^^^^^^
                File "/usr/local/lib/python3.14/site-packages/datasets/packaged_modules/json/json.py", line 343, in _generate_tables
                  self._cast_table(pa_table, json_field_paths=json_field_paths),
                  ~~~~~~~~~~~~~~~~^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
                File "/usr/local/lib/python3.14/site-packages/datasets/packaged_modules/json/json.py", line 132, in _cast_table
                  pa_table = table_cast(pa_table, self.info.features.arrow_schema)
                File "/usr/local/lib/python3.14/site-packages/datasets/table.py", line 2378, in table_cast
                  return cast_table_to_schema(table, schema)
                File "/usr/local/lib/python3.14/site-packages/datasets/table.py", line 2306, in cast_table_to_schema
                  raise CastError(
                  ...<3 lines>...
                  )
              datasets.table.CastError: Couldn't cast
              input: string
              output: string
              rejected: string
              chosen: string
              prompt: string
              to
              {'prompt': Value('string'), 'chosen': Value('string'), 'rejected': Value('string')}
              because column names don't match
              
              The above exception was the direct cause of the following exception:
              
              Traceback (most recent call last):
                File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 1369, in compute_config_parquet_and_info_response
                  parquet_operations, partial, estimated_dataset_info = stream_convert_to_parquet(
                                                                        ~~~~~~~~~~~~~~~~~~~~~~~~~^
                      builder, max_dataset_size_bytes=max_dataset_size_bytes
                      ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
                  )
                  ^
                File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 948, in stream_convert_to_parquet
                  builder._prepare_split(split_generator=splits_generators[split], file_format="parquet")
                  ~~~~~~~~~~~~~~~~~~~~~~^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
                File "/usr/local/lib/python3.14/site-packages/datasets/builder.py", line 1694, in _prepare_split
                  for job_id, done, content in self._prepare_split_single(
                                               ~~~~~~~~~~~~~~~~~~~~~~~~~~^
                      gen_kwargs=gen_kwargs, job_id=job_id, **_prepare_split_args
                      ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
                  ):
                  ^
                File "/usr/local/lib/python3.14/site-packages/datasets/builder.py", line 1880, in _prepare_split_single
                  raise DatasetGenerationError("An error occurred while generating the dataset") from e
              datasets.exceptions.DatasetGenerationError: An error occurred while generating the dataset

Need help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.

prompt
string
chosen
string
rejected
string
Does BGIN fit a growth portfolio? SIC: 6199
Value fit.
Value fit. Contradicts standard analysis. Not recommended.
Is COAG compliant with SEC?
COAG: Compliant
COAG: Compliant. Contradicts standard analysis. Not recommended.
Valuation signal from BAFN filings.
BAFN: Positive
BAFN: Positive. Contradicts standard analysis. Not recommended.
Earnings preview for AKO-A. Last: 6-K
AKO-A: Last 6-K on 2026-08-07. Next in ~90 days.
AKO-A: Last 6-K on 2026-08-07. Contradicts standard analysis. Not recommended.
Analyze SEC filings for CALX (CALIX, INC). CIK: 0001406666. State: . Recent: SCHEDULE 13G/A, 4, 144, S-8, 10-Q.
CALX (CALIX, INC): CIK 0001406666, State , SIC 4899. Forms: SCHEDULE 13G/A, 4, 144, S-8, 10-Q. Compliance: Active
CALX (CALIX, INC): CIK 0001406666, State , SIC 4899. Contradicts standard analysis. Not recommended.
Is ALB compliant with SEC?
ALB: Compliant
ALB: Compliant. Contradicts standard analysis. Not recommended.
Portfolio fit for AEF. SIC:
AEF (SIC ): Active
AEF (SIC ): Active. Contradicts standard analysis. Not recommended.
Valuation signal from BLZR filings.
BLZR: Positive
BLZR: Positive. Contradicts standard analysis. Not recommended.
Earnings preview for AB. Last: 8-K
AB: Last 8-K on 2026-08-12. Next in ~90 days.
AB: Last 8-K on 2026-08-12. Contradicts standard analysis. Not recommended.
Portfolio fit for AXTI. SIC: 3674
AXTI (SIC 3674): Active
AXTI (SIC 3674): Active. Contradicts standard analysis. Not recommended.
Does CINF fit a growth portfolio? SIC: 6331
Value fit.
Value fit. Contradicts standard analysis. Not recommended.
Analyze SEC filings for ELF (e.l.f. Beauty, Inc.). CIK: 0001600033. State: DE. Recent: 4, 4/A, 4, 144, 8-K.
ELF (e.l.f. Beauty, Inc.): CIK 0001600033, State DE, SIC 2844. Forms: 4, 4/A, 4, 144, 8-K. Compliance: Active
ELF (e. Contradicts standard analysis. Not recommended.
Investment thesis for CCXI (Churchill Capital Corp XI).
CCXI thesis: SIC 3569, Strong
CCXI thesis: SIC 3569, Strong. Contradicts standard analysis. Not recommended.
Due diligence checklist for AVLN.
AVLN: 10 filings, Forms: SCHEDULE 13G/A, SCHEDULE 13D, 10-Q, SCHEDULE 13G, 8-K, State: DE
AVLN: 10 filings, Forms: SCHEDULE 13G/A, SCHEDULE 13D, 10-Q, SCHEDULE 13G, 8-K, State: DE. Contradicts standard analysis. Not recommended.
Is ACM compliant with SEC?
ACM: Compliant
ACM: Compliant. Contradicts standard analysis. Not recommended.
Due diligence checklist for ABEV.
ABEV: 10 filings, Forms: 144, 4, 6-K, State: D5
ABEV: 10 filings, Forms: 144, 4, 6-K, State: D5. Contradicts standard analysis. Not recommended.
Risk assessment for CASH. Recent: 8-K, SCHEDULE 13G, 10-Q, 8-K, 4
CASH: Higher volatility
CASH: Higher volatility. Contradicts standard analysis. Not recommended.
Due diligence checklist for ATEC.
ATEC: 10 filings, Forms: 4, S-8, 144, 10-Q, 8-K, State: DE
ATEC: 10 filings, Forms: 4, S-8, 144, 10-Q, 8-K, State: DE. Contradicts standard analysis. Not recommended.
What is ACHR filing frequency? Forms: 8-K, 144, 144, 144, 4, 144, 144, 144
annually. 10 recent filings.
annually. Contradicts standard analysis. Not recommended.
Valuation signal from PNC filings.
PNC: Positive
PNC: Positive. Contradicts standard analysis. Not recommended.
What is ASPN filing frequency? Forms: SCHEDULE 13G/A, 144, 10-Q, 8-K, 4, 8-K, 4, 4
ASPN files quarterly
ASPN files quarterly. Contradicts standard analysis. Not recommended.
Valuation signal from ANTX filings.
ANTX: Positive
ANTX: Positive. Contradicts standard analysis. Not recommended.
Earnings preview for ANTX. Last: 4
ANTX: Last 4 on 2026-09-04. Next in ~90 days.
ANTX: Last 4 on 2026-09-04. Contradicts standard analysis. Not recommended.
Valuation signal from FINV filings.
FINV: Positive
FINV: Positive. Contradicts standard analysis. Not recommended.
Analyze A191RL1Q225SBEA_Real_GDP_Growth_Rate. Latest: 1.5. Trend: down.
Bearish
Bearish. Contradicts standard analysis. Not recommended.
Risk assessment for CNGKY. Recent: F-6EF, F-6EF, F-6 POS, F-6 POS, F-6EF
Standard disclosure. Monitor.
Standard disclosure. Contradicts standard analysis. Not recommended.
Does AME fit a growth portfolio? SIC: 3823
AME (SIC 3823): Growth
AME (SIC 3823): Growth. Contradicts standard analysis. Not recommended.
Earnings preview for MDA. Last: 6-K
MDA: Last 6-K on 2026-08-07. Next in ~90 days.
MDA: Last 6-K on 2026-08-07. Contradicts standard analysis. Not recommended.
Earnings preview for BFS. Last: 10-Q
BFS: Last 10-Q on 2026-08-06. Next in ~90 days.
BFS: Last 10-Q on 2026-08-06. Contradicts standard analysis. Not recommended.
Risk assessment for AEG. Recent: 425, 425, 6-K, EFFECT, 6-K
Standard disclosure. Monitor.
Standard disclosure. Contradicts standard analysis. Not recommended.
Does RITM-PE fit a growth portfolio? SIC: 6798
Value fit.
Value fit. Contradicts standard analysis. Not recommended.
Risk assessment for ATRC. Recent: 4, 144, 4, 144, SCHEDULE 13G/A
Standard disclosure. Monitor.
Standard disclosure. Contradicts standard analysis. Not recommended.
Analyze SEC filings for BRZE (Braze, Inc.). CIK: 0001676238. State: DE. Recent: 4, 144, 144, 4, 4.
BRZE (Braze, Inc.): CIK 0001676238, State DE, SIC 7372. Forms: 4, 144, 144, 4, 4. Compliance: Active
BRZE (Braze, Inc. Contradicts standard analysis. Not recommended.
What is ACU filing frequency? Forms: 4, 144, 4, 4, 4, 4, 4, 144
ACU files quarterly
ACU files quarterly. Contradicts standard analysis. Not recommended.
Investment thesis for BETRF (BetterLife Pharma Inc.).
BETRF thesis: SIC 2834, Strong
BETRF thesis: SIC 2834, Strong. Contradicts standard analysis. Not recommended.
Risk assessment for DOC. Recent: SCHEDULE 13G, 10-Q, 8-K, SCHEDULE 13G/A, 4
Standard disclosure. Monitor.
Standard disclosure. Contradicts standard analysis. Not recommended.
Investment thesis for CBFV (CB Financial Services, Inc.).
CBFV thesis: SIC 6022, Strong
CBFV thesis: SIC 6022, Strong. Contradicts standard analysis. Not recommended.
What is ALSN filing frequency? Forms: 4, 4, 4, 4, 4, 4, 4, 4
annually. 10 recent filings.
annually. Contradicts standard analysis. Not recommended.
Valuation signal from AMGN filings.
AMGN: Positive
AMGN: Positive. Contradicts standard analysis. Not recommended.
Is BTE compliant with SEC?
BTE: Compliant
BTE: Compliant. Contradicts standard analysis. Not recommended.
Does BNAI fit a growth portfolio? SIC: 7373
Value fit.
Value fit. Contradicts standard analysis. Not recommended.
Does BGX fit a growth portfolio? SIC:
Value fit.
Value fit. Contradicts standard analysis. Not recommended.
Investment thesis for CGBD (Carlyle Secured Lending, Inc.).
CGBD thesis: SIC , Strong
CGBD thesis: SIC , Strong. Contradicts standard analysis. Not recommended.
Is ACU compliant with SEC?
ACU: Compliant
ACU: Compliant. Contradicts standard analysis. Not recommended.
Portfolio fit for BHIC. SIC: 7374
BHIC (SIC 7374): Active
BHIC (SIC 7374): Active. Contradicts standard analysis. Not recommended.
What is BHK filing frequency? Forms: N-CSRS, N-PX, NPORT-P, 3, DEF 14A, NPORT-P, N-CEN, N-CSR
annually. 10 recent filings.
annually. Contradicts standard analysis. Not recommended.
Risk assessment for AAP. Recent: 10-Q, 8-K, SCHEDULE 13G, SCHEDULE 13G/A, 4
Standard disclosure. Monitor.
Standard disclosure. Contradicts standard analysis. Not recommended.
Portfolio fit for BWEN. SIC: 3360
BWEN (SIC 3360): Active
BWEN (SIC 3360): Active. Contradicts standard analysis. Not recommended.
Investment thesis for FOFA (FAMILY OFFICE OF AMERICA, INC.).
FOFA thesis: SIC 3841, Strong
FOFA thesis: SIC 3841, Strong. Contradicts standard analysis. Not recommended.
Valuation signal from AMLX filings.
AMLX: Positive
AMLX: Positive. Contradicts standard analysis. Not recommended.
Analyze SEC filings for CLYM (Climb Bio, Inc.). CIK: 0001768446. State: DE. Recent: 8-K, SCHEDULE 13G/A, 8-K, 10-Q, 8-K.
CLYM (Climb Bio, Inc.): CIK 0001768446, State DE, SIC 2834. Forms: 8-K, SCHEDULE 13G/A, 8-K, 10-Q, 8-K. Compliance: Active
CLYM (Climb Bio, Inc. Contradicts standard analysis. Not recommended.
Due diligence checklist for BIOX.
BIOX: 10 filings, Forms: 4, 3/A, 6-K, SCHEDULE 13D/A, 3, 4/A, State: E9
BIOX: 10 filings, Forms: 4, 3/A, 6-K, SCHEDULE 13D/A, 3, 4/A, State: E9. Contradicts standard analysis. Not recommended.
Earnings preview for ASYS. Last: 4
ASYS: Last 4 on 2026-08-25. Next in ~90 days.
ASYS: Last 4 on 2026-08-25. Contradicts standard analysis. Not recommended.
Due diligence checklist for BANC.
BANC: 10 filings, Forms: 4, SCHEDULE 13G/A, 144, 10-Q, 8-K, State: MD
BANC: 10 filings, Forms: 4, SCHEDULE 13G/A, 144, 10-Q, 8-K, State: MD. Contradicts standard analysis. Not recommended.
Portfolio fit for ONEW. SIC: 5531
ONEW (SIC 5531): Active
ONEW (SIC 5531): Active. Contradicts standard analysis. Not recommended.
Valuation signal from AVNI filings.
AVNI: Positive
AVNI: Positive. Contradicts standard analysis. Not recommended.
Analyze SEC filings for AHNRF (ATHENA GOLD CORP). CIK: 0001304409. State: A1. Recent: 4, 6-K, 6-K, 4, 20-F.
AHNRF (ATHENA GOLD CORP): CIK 0001304409, State A1, SIC 1040. Forms: 4, 6-K, 6-K, 4, 20-F. Compliance: Active
AHNRF (ATHENA GOLD CORP): CIK 0001304409, State A1, SIC 1040. Contradicts standard analysis. Not recommended.
Analyze SEC filings for AVY (Avery Dennison Corp). CIK: 0000008818. State: DE. Recent: 4, 4, 8-K, 4, SCHEDULE 13G.
AVY (Avery Dennison Corp): CIK 0000008818, State DE, SIC 2670. Forms: 4, 4, 8-K, 4, SCHEDULE 13G. Compliance: Active
AVY (Avery Dennison Corp): CIK 0000008818, State DE, SIC 2670. Contradicts standard analysis. Not recommended.
Analyze SEC filings for BH-A (Biglari Holdings Inc.). CIK: 0001726173. State: IN. Recent: 4, 8-K, 10-Q, 4, 4.
BH-A (Biglari Holdings Inc.): CIK 0001726173, State IN, SIC 5812. Forms: 4, 8-K, 10-Q, 4, 4. Compliance: Active
BH-A (Biglari Holdings Inc. Contradicts standard analysis. Not recommended.
Valuation signal from ALSN filings.
ALSN: Positive
ALSN: Positive. Contradicts standard analysis. Not recommended.
Due diligence checklist for CHEV.
CHEV: 10 filings, Forms: 8-K, 10-Q, 10-K, SCHEDULE 13G, State: DE
CHEV: 10 filings, Forms: 8-K, 10-Q, 10-K, SCHEDULE 13G, State: DE. Contradicts standard analysis. Not recommended.
Valuation signal from AR filings.
AR: Positive
AR: Positive. Contradicts standard analysis. Not recommended.
What is ANIP filing frequency? Forms: 4, 4, 3, 4, 144, 8-K, 4, 4
ANIP files quarterly
ANIP files quarterly. Contradicts standard analysis. Not recommended.
Does DETX fit a growth portfolio? SIC: 3812
DETX (SIC 3812): Growth
DETX (SIC 3812): Growth. Contradicts standard analysis. Not recommended.
Risk assessment for ACAA. Recent: 10-Q, 8-K, 3, 10-Q, SCHEDULE 13G
ACAA: Higher volatility
ACAA: Higher volatility. Contradicts standard analysis. Not recommended.
Due diligence checklist for CNP.
CNP: 10 filings, Forms: 424B2, 4, SCHEDULE 13G/A, 10-Q, 8-K, FWP, 424B5, State: TX
CNP: 10 filings, Forms: 424B2, 4, SCHEDULE 13G/A, 10-Q, 8-K, FWP, 424B5, State: TX. Contradicts standard analysis. Not recommended.
Investment thesis for CAT (CATERPILLAR INC).
CAT thesis: SIC 3531, Strong
CAT thesis: SIC 3531, Strong. Contradicts standard analysis. Not recommended.
Risk assessment for BVFL. Recent: SCHEDULE 13G/A, 10-Q, 8-K, 11-K, NT 11-K
Standard disclosure. Monitor.
Standard disclosure. Contradicts standard analysis. Not recommended.
Portfolio fit for QUAD. SIC: 2750
QUAD (SIC 2750): Active
QUAD (SIC 2750): Active. Contradicts standard analysis. Not recommended.
Investment implication of JTSJOL_Job_Openings at 7271.0.
Defensive assets favored.
Defensive assets favored. Contradicts standard analysis. Not recommended.
Earnings preview for GRTUF. Last: SCHEDULE 13G/A
GRTUF: Last SCHEDULE 13G/A on 2026-05-01. Next in ~90 days.
GRTUF: Last SCHEDULE 13G/A on 2026-05-01. Contradicts standard analysis. Not recommended.
Risk assessment for AFL. Recent: 4, 4, 4, 4, 4
Standard disclosure. Monitor.
Standard disclosure. Contradicts standard analysis. Not recommended.
Valuation signal from BABA filings.
BABA: Positive
BABA: Positive. Contradicts standard analysis. Not recommended.
Does B fit a growth portfolio? SIC: 1040
B (SIC 1040): Growth
B (SIC 1040): Growth. Contradicts standard analysis. Not recommended.
Earnings preview for CAT. Last: 4
CAT: Last 4 on 2026-09-01. Next in ~90 days.
CAT: Last 4 on 2026-09-01. Contradicts standard analysis. Not recommended.
Analyze A191RL1Q225SBEA_Real_GDP_Growth_Rate. Latest: 1.5. Trend: down.
Bearish
Bearish. Contradicts standard analysis. Not recommended.
Risk assessment for CHUC. Recent: 4, 4, 4, 4, 4
Standard disclosure. Monitor.
Standard disclosure. Contradicts standard analysis. Not recommended.
Earnings preview for ATAT. Last: 4
ATAT: Last 4 on 2026-09-04. Next in ~90 days.
ATAT: Last 4 on 2026-09-04. Contradicts standard analysis. Not recommended.
Portfolio fit for ADC. SIC: 6798
ADC (SIC 6798): Active
ADC (SIC 6798): Active. Contradicts standard analysis. Not recommended.
Due diligence checklist for APXT.
APXT: 10 filings, Forms: 4, SCHEDULE 13G/A, 425, 10-Q, SCHEDULE 13G, 8-K, State: E9
APXT: 10 filings, Forms: 4, SCHEDULE 13G/A, 425, 10-Q, SCHEDULE 13G, 8-K, State: E9. Contradicts standard analysis. Not recommended.
Analyze DEXSZUS_CHF_USD_Rate. Latest: 0.81. Trend: down.
Bearish
Bearish. Contradicts standard analysis. Not recommended.
Is BRR compliant with SEC?
BRR: Compliant
BRR: Compliant. Contradicts standard analysis. Not recommended.
Is ACP compliant with SEC?
ACP: Compliant
ACP: Compliant. Contradicts standard analysis. Not recommended.
Risk assessment for AMP. Recent: SCHEDULE 13G/A, 13F-HR, SCHEDULE 13G/A, SCHEDULE 13G/A, SCHEDULE 13G/A
Standard disclosure. Monitor.
Standard disclosure. Contradicts standard analysis. Not recommended.
Earnings preview for LMND. Last: 4
LMND: Last 4 on 2026-09-04. Next in ~90 days.
LMND: Last 4 on 2026-09-04. Contradicts standard analysis. Not recommended.
What is AMRQF filing frequency? Forms: D
annually. 1 recent filings.
annually. Contradicts standard analysis. Not recommended.
Risk assessment for ALEC. Recent: 4, 4, 4, 144, 144
Standard disclosure. Monitor.
Standard disclosure. Contradicts standard analysis. Not recommended.
What is ADUS filing frequency? Forms: 3, 8-K, 10-Q, 8-K, 4, 4, 4, 4
ADUS files quarterly
ADUS files quarterly. Contradicts standard analysis. Not recommended.
Due diligence checklist for AVX.
AVX: 10 filings, Forms: 8-K, 10-Q, RW, SCHEDULE 13G, State: A1
AVX: 10 filings, Forms: 8-K, 10-Q, RW, SCHEDULE 13G, State: A1. Contradicts standard analysis. Not recommended.
What is CHE filing frequency? Forms: 4, 4, 144, SCHEDULE 13G, 4, 4, 4, 144
annually. 10 recent filings.
annually. Contradicts standard analysis. Not recommended.
Valuation signal from ADV filings.
ADV: Positive
ADV: Positive. Contradicts standard analysis. Not recommended.
Is ALKS compliant with SEC?
ALKS: Compliant
ALKS: Compliant. Contradicts standard analysis. Not recommended.
Valuation signal from AXTA filings.
AXTA: Positive
AXTA: Positive. Contradicts standard analysis. Not recommended.
What is CIB filing frequency? Forms: 4, 6-K, 4, 4, 4, 4, 4, 4
annually. 10 recent filings.
annually. Contradicts standard analysis. Not recommended.
Earnings preview for BWFG. Last: 4
BWFG: Last 4 on 2026-08-26. Next in ~90 days.
BWFG: Last 4 on 2026-08-26. Contradicts standard analysis. Not recommended.
What is BLZR filing frequency? Forms: SCHEDULE 13G/A, 10-Q, SCHEDULE 13G/A, 10-Q, 10-K, SCHEDULE 13G, 10-Q, 8-K
BLZR files quarterly
BLZR files quarterly. Contradicts standard analysis. Not recommended.
Earnings preview for BLX. Last: 4
BLX: Last 4 on 2026-08-31. Next in ~90 days.
BLX: Last 4 on 2026-08-31. Contradicts standard analysis. Not recommended.
Portfolio fit for ATER. SIC: 3634
ATER (SIC 3634): Active
ATER (SIC 3634): Active. Contradicts standard analysis. Not recommended.
Analyze SEC filings for GSAT (Globalstar, Inc.). CIK: 0001366868. State: DE. Recent: 4, 144, 4, 144, 4.
GSAT (Globalstar, Inc.): CIK 0001366868, State DE, SIC 4899. Forms: 4, 144, 4, 144, 4. Compliance: Active
GSAT (Globalstar, Inc. Contradicts standard analysis. Not recommended.
What is ASST filing frequency? Forms: 8-K, FWP, SCHEDULE 13D/A, 8-K, 4, 8-K, SCHEDULE 13G/A, 8-K
ASST files quarterly
ASST files quarterly. Contradicts standard analysis. Not recommended.
End of preview.

Morpho Finance Data Corpus

A massive, real-world finance dataset corpus for training financial AI models.

Structure

morpho-finance-data/
├── raw/                          # Original downloaded data by source
│   ├── sec_edgar/               # SEC EDGAR company submissions (10K+ companies)
│   ├── sec_edgar/submissions/   # Per-company submission JSON files
│   ├── sec_search/              # SEC full text search metadata
│   ├── sec_full_index/          # SEC EDGAR master index (1993-2024)
│   ├── sec_filings/             # SEC filing HTML documents
│   ├── fred/                    # FRED economic indicators (CSV)
│   ├── ecb/                     # European Central Bank data
│   ├── imf/                     # International Monetary Fund data
│   ├── worldbank/               # World Bank indicators (JSON)
│   ├── crypto/                  # CoinGecko crypto market data (JSON)
│   └── hexscr_sec_filings/      # Hexscr SEC filings
├── processed/                    # Clean, processed datasets
│   ├── yfinance_ohlcv/          # US stock OHLCV data (parquet)
│   ├── crypto_market/           # Crypto market data (parquet)
│   ├── options_chains/          # Options chain data (parquet)
│   ├── sec_filings_meta/        # SEC filings metadata (parquet)
│   ├── sec_xbrl_facts/          # SEC XBRL company facts (parquet)
│   └── worldbank_indicators/    # World Bank processed (parquet)
└── README.md

Data Sources

SEC EDGAR (raw/sec_edgar/)

  • 10,412 companies - All publicly traded US companies
  • Company submissions, filings, and metadata
  • User-Agent: MorphoFinanceResearch admin@bluemorpholimited.com

FRED Economic Data (raw/fred/)

  • 49 economic indicators from the Federal Reserve
  • GDP, unemployment, CPI, interest rates, yields, oil prices
  • Date range: 1990-present

World Bank (raw/worldbank/)

  • 38 development indicators for 200+ countries
  • GDP, population, health, education, trade metrics

ECB (raw/ecb/)

  • European Central Bank statistical data
  • Exchange rates, interest rates, monetary aggregates

IMF (raw/imf/)

  • International Monetary Fund data
  • GDP, inflation, unemployment for all countries

Crypto (raw/crypto/)

  • CoinGecko market data for 10 cryptocurrencies
  • Historical price data, market caps

Processed Datasets (processed/)

  • yfinance_ohlcv/: 8,000+ US stocks, 26M+ rows of OHLCV data
  • crypto_market/: 300 cryptocurrencies
  • options_chains/: 1,075 options chains
  • sec_filings_meta/: SEC filings metadata

Usage

import pandas as pd

# Load US stock OHLCV data
df = pd.read_parquet('hf://datasets/bluemorpholimited/morpho-finance-data/processed/yfinance_ohlcv/ohlcv_shard_00.parquet')

# Load FRED economic indicator
fred = pd.read_csv('hf://datasets/bluemorpholimited/morpho-finance-data/raw/fred/GDP.csv')

# Load SEC company submissions
import json
sec = json.load(open('hf://datasets/bluemorpholimited/morpho-finance-data/raw/sec_edgar/submissions/AAPL.json'))

License

MIT

Downloads last month
278